Clinical Trials Directory

Trials / Completed

CompletedNCT02724891

Web-based Validation Pelvic Floor Questionnaires

Validation of Electronic (Web-based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Columbia University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patient-reported outcomes are commonly used in healthcare. Examples include validated symptom-based questionnaires and health diaries. In the field of Female Pelvic Medicine and Reconstructive Surgery there are many questionnaires and diaries that have been validated for a paper-based administration. As technology is incorporated into delivery of medical care and research, investigators need to consider how to collect data electronically while ensuring that this new format is equivalent to the paper questionnaires they rely on. In this study, the investigators aim to validate a series of validated questionnaires and symptom diaries administered via the web and smartphone for a more streamlined care for the patients.

Detailed description

Health questionnaires and health diaries are two forms of patient-reported outcomes (PRO) commonly used in healthcare. Health questionnaires are often used as intake logs, discerning and recording the symptoms and severity of a problem at the time of presentation. Health diaries, in contrast, are ongoing logs which allow for mindful attention to symptoms and monitoring of response to therapy. Unfortunately, both types of PRO forms are often under-utilized or uninterpretable because they are collected on paper. Within urogynecology, PRO scales such as the Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire (PFIQ), Bristol Stool Chart, Bladder Diaries and others are used ubiquitously. Their impact, however, is diminished by poor compliance and recall bias. The move towards electronic PRO measures would be endorsed by patients (who can track and interact with their data), physicians (who can track progress and study group outcomes) and by regulators (who want to ensure accurate and reproducible data collection). Electronic PRO tools, particularly on the patient's own device, would allow for increased rate of reporting through mobile availability, time stamping of data to prevent recall bias and reduction in data entry mistakes and costs. Study Procedures After informed consent is obtained, demographic data will be collected. Subjects will be administered the questionnaires either in paper or web-based or smartphone form based on a random number block scheme. At least two weeks later but prior to treatment they will complete the other form of the questionnaire. This can occur at their next office visit or can be completed at home. Subjects will be emailed and/or called by research staff to remind them to complete the second set of questionnaires.

Conditions

Interventions

TypeNameDescription
OTHERpaper formquestionnaires in paper form
OTHERweb/smartphone formquestionnaires in web/smartphone

Timeline

Start date
2015-02-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2016-03-31
Last updated
2019-04-01

Locations

5 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02724891. Inclusion in this directory is not an endorsement.